Search Results - "Probert C"

Review article: steroid resistance in inflammatory bowel disease – mechanisms and therapeutic strategies.

Authors: CREED, T. J. PROBERT, C. S. J.

Source: Alimentary Pharmacology & Therapeutics. Jan2007, Vol. 25 Issue 2, p111-122. 12p. 2 Diagrams, 4 Charts.

Review article: maintenance therapy in patients with ulcerative colitis.

Authors: ORCHARD, T. PROBERT, C. S. KESHAV, S.

Source: Alimentary Pharmacology & Therapeutics. Sep2006 Supplement, Vol. 24, p17-22. 6p. 2 Charts, 2 Graphs.

Basiliximab for the treatment of steroid-resistant ulcerative colitis: further experience in moderate and severe disease.

Authors: CREED, T. J. PROBERT, C. S. J. NORMAN, M. N. et al.

Source: Alimentary Pharmacology & Therapeutics. May2006, Vol. 23 Issue 10, p1435-1442. 8p. 2 Charts, 4 Graphs.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Combined oral and enema treatment with Pentasa (mesalazine) is superior to oral therapy alone in patients with extensive mild/moderate active ulcerative colitis: a randomised, double blind, placebo controlled study.

Authors: Marteau, P. Probert, C. S. Lincigren, S. et al.

Source: Gut (0017-5749). Jul2005, Vol. 54 Issue 7, p960-965. 6p.

A novel method for rapidly diagnosing the causes of diarrhoea.

Authors: Probert C S J Jones P R H Ratcliffe N M

Source: Gut (0017-5749). Jan2004, Vol. 53 Issue 1, p58-61. 4p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

The Emerging Short Chain Fatty Acid Enriched Metabotype in Irritable Bowel Syndrome and Its Potential Clinical Relevance.

Authors: Conley, T. E. Duncan, A. Modasia, A. et al.

Source: Alimentary Pharmacology & Therapeutics. Jul2026, Vol. 64 Issue 2, p208-221. 14p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Pulse cyclophosphamide in steroid-resistant inflammatory bowel disease: authors’ reply.

Authors: Creed, T. J. Probert, C.

Source: Alimentary Pharmacology & Therapeutics. Jun2007, Vol. 25 Issue 11, p1364-1364. 1p.

This result is not displayed to guests.
Login for full access.

This result is not displayed to guests.
Login for full access.

Basiliximab (anti-CD25) in combination with steroids may be an effective new treatment for steroid-resistant ulcerative colitis.

Authors: Creed, T. J. Norman, M. R. Probert, C. S. J. et al.

Source: Alimentary Pharmacology & Therapeutics. Jul2003, Vol. 18 Issue 1, p65-75. 11p. 1 Chart.